Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -97.71%78.62K | 1,650.27%9.09M | 117.06%110.89K | 381.27%8.7M | 902.19%6.51M | 3.43M | -586.49K | 59.37%-650.09K | 147.19%1.81M | 201.06%649.63K |
| Net income from continuing operations | -74.11%840.19K | 135.45%1.01M | 125.73%372.53K | 60.08%-2.22M | ---1.19M | --3.24M | ---2.84M | 1.20%-1.45M | 31.18%-5.57M | --0 |
| Operating gains losses | -1,063.58%-420.08K | 186.02%224.85K | -2.20%166.18K | 145.06%46.22K | --173.8K | ---36.1K | ---261.39K | -68.39%169.91K | ---102.58K | --0 |
| Depreciation and amortization | -67.99%41.96K | -60.44%35.51K | -13.28%39.1K | -22.59%175.65K | ---90.28K | --131.07K | --89.76K | 12.49%45.09K | 37.14%226.9K | --0 |
| Remuneration paid in stock | --38.3K | ---- | ---- | -82.82%434.97K | ---- | ---- | ---- | ---- | -24.74%2.53M | --0 |
| Other non cashItems | ---5.57K | --1.81M | -110.21%-1.82M | 25.46%799.74K | ---- | ---- | ---- | -12.20%-865.18K | 3,448.92%637.43K | -67.88%649.63K |
| Change In working capital | -339.87%-416.19K | 304.32%5.94M | -6.62%1.35M | 131.75%9.47M | --6.38M | --173.51K | --1.47M | 371.94%1.45M | 442.19%4.09M | --0 |
| -Change in receivables | -107.95%-616.28K | 117.69%883.99K | 1,513.98%1.73M | 67.43%-896.18K | ---3.53M | --7.75M | ---5M | -111.14%-122.3K | -7.69%-2.75M | --0 |
| -Change in inventory | 311.97%1.28M | ---- | ---- | -9.16%584.65K | --44.2K | --311.22K | ---- | ---- | 152.04%643.6K | --0 |
| -Change in prepaid assets | 227.55%471.36K | ---- | ---- | 61.35%-208.47K | --587.09K | ---369.56K | ---- | ---- | ---539.42K | --0 |
| -Change in payables and accrued expense | 128.65%1.97M | 65.13%4.3M | -122.13%-377.47K | 339.86%7.28M | --9.85M | ---6.88M | --2.61M | 200.56%1.71M | -66.20%1.65M | --0 |
| -Change in other current assets | ---- | ---- | ---- | -92.52%4.78K | ---- | ---- | --52.1K | -305.91%-135.46K | 198.40%63.95K | --0 |
| -Change in other working capital | -390.12%-3.53M | ---- | ---- | -46.04%2.71M | ---582.79K | ---719.33K | ---- | ---- | 1,850.08%5.01M | --0 |
| Interest paid (cash flow from operating activities) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -97.71%78.62K | 1,650.27%9.09M | 117.06%110.89K | 381.27%8.7M | 902.19%6.51M | --3.43M | ---586.49K | 59.37%-650.09K | 147.19%1.81M | 201.06%649.63K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 152.70%83.65K | 91.18%-8.08K | -88.74%4.16K | -108.02%-118.48K | 94.95K | -110.74%-158.73K | -153.27%-91.63K | 121.47%36.93K | 173.86%1.48M | 0 |
| Net PPE purchase and sale | ---- | ---- | --8.35K | 22.65%-17.6K | --121.3K | ---- | ---- | ---- | ---22.75K | --0 |
| Net other investing changes | 498.67%79.04K | 100.30%275 | -111.36%-4.19K | -106.73%-100.88K | ---26.35K | ---19.83K | ---91.63K | 121.47%36.93K | 175.00%1.5M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 152.70%83.65K | 91.18%-8.08K | -88.74%4.16K | -108.02%-118.48K | --94.95K | -110.74%-158.73K | -153.27%-91.63K | 121.47%36.93K | 173.86%1.48M | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 103.08%71.6K | -930.10%-1.37M | -15.62%-1.12M | -1,448.23%-3.77M | 2.31%-634.63K | -281.80%-2.33M | 108.04%165.26K | -156.91%-970.01K | -86.08%279.45K | -121.74%-649.63K |
| Net issuance payments of debt | 103.07%71.6K | -367.56%-1.37M | -15.62%-1.12M | -4,696.39%-3.77M | ---169.01K | -638.60%-2.34M | 85.73%-293.41K | -156.91%-970.01K | -94.75%81.97K | --0 |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -55.75%197.48K | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | --6.95K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 103.08%71.6K | -930.10%-1.37M | -15.62%-1.12M | -1,448.23%-3.77M | 2.31%-634.63K | -281.80%-2.33M | 108.04%165.26K | -156.91%-970.01K | -86.08%279.45K | -121.74%-649.63K |
| Net cash flow | ||||||||||
| Beginning cash position | 491.56%16.39M | 164.25%8.68M | 98.96%9.68M | 273.91%4.87M | -23.73%3.71M | 11.43%2.77M | 166.08%3.28M | 273.91%4.87M | -74.61%1.3M | 258.20%4.87M |
| Current changes in cash | -75.15%233.87K | 1,603.80%7.71M | 36.43%-1.01M | 35.10%4.82M | --5.97M | -60.46%941.1K | -140.95%-512.85K | -2,243.02%-1.58M | 193.22%3.56M | --0 |
| End cash Position | 347.86%16.62M | 491.56%16.39M | 164.25%8.68M | 98.96%9.68M | 98.96%9.68M | -23.73%3.71M | 11.43%2.77M | 166.08%3.28M | 273.91%4.87M | 273.91%4.87M |
| Free cash from | -97.61%78.62K | 1,650.27%9.09M | 117.06%110.89K | 386.42%8.68M | 920.87%6.63M | 921.28%3.29M | -118.70%-586.49K | 59.37%-650.09K | 146.59%1.79M | 202.13%649.63K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.